L-Tetrahydropalmatine
L-THP / Corydalis extract
L-Tetrahydropalmatine (L-THP / Corydalis extract) is a cognitive & mood research compound. Dopamine D1 and D2 receptor antagonist from Corydalis yanhusuo, used in traditional Chinese medicine for pain and sleep. The analgesia appears to be dopaminergic rather than opioid.
L-Tetrahydropalmatine quick facts
| Reported research dose | 100–200mg (research) |
| Route | Oral |
| Frequency | 1x · Sparingly |
| Half-life | ~2–4 hours |
| Forms | Oral |
| Evidence level | Human trials in China for pain and insomnia; some data on reducing cocaine craving |
Non-opioid analgesia with a genuinely different mechanism is a rare thing and that's what makes this interesting. ⚠️ It is a dopamine antagonist — sedation, and with repeated use the extrapyramidal effects you'd expect from that class. Hepatotoxicity has been reported with Corydalis preparations. Not something to take daily.
How L-Tetrahydropalmatine works
Dopamine D1 and D2 receptor antagonist from Corydalis yanhusuo, used in traditional Chinese medicine for pain and sleep. The analgesia appears to be dopaminergic rather than opioid.
Proposed benefits
Researched for focus, memory, neuroprotection, mood and stress resilience.
✅ Clinically validated
- Used clinically in China as an analgesic and sedative, with Chinese clinical literature behind it. Small Western trials have examined it for cocaine dependence, reporting reduced use — a genuinely interesting application that has not been pursued at scale.
📊 Correlative data
- Long traditional use as a component of *Corydalis yanhusuo* in Chinese medicine, and modern use for pain and sleep. Hepatotoxicity case reports exist, mostly linked to adulterated or mislabelled products rather than to the isolated alkaloid.
🧪 Theoretical / extrapolated
- An isoquinoline alkaloid acting as a dopamine D1 and D2 antagonist with additional GABAergic activity.
- Dopamine antagonism is an unusual mechanism for something sold as a wellness compound, and it predicts the risks that framing hides: sedation, and the theoretical possibility of extrapyramidal effects with sustained use, the same class of effect antipsychotics cause.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
L-Tetrahydropalmatine — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- This class is broad, but the predicted problems cluster by mechanism rather than by molecule. Cholinergics (racetams, and anything raising acetylcholine) predict headache — the classic one, from choline demand outrunning supply. Dopaminergics and eugeroics predict tolerance, sleep disruption and a flat mood on the days off. Anything glutamatergic or AMPA-facing carries a theoretical excitotoxicity concern at high doses.
- The pattern worth internalising: anything that borrows performance from tomorrow eventually presents the bill. Sleep is the most common currency it gets paid in.
What has actually been reported
- Headache is the most reported effect across the racetam family and usually responds to added choline.
- Irritability, blunted affect and a rebound low on cessation are commonly reported with the stimulant-adjacent members.
- Most of this class has little or no controlled human safety data at the doses actually used.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- Take a choline source with any racetam. The headache is the mechanism running out of substrate, and it is largely preventable rather than something to push through.
- Dose in the morning. Almost everything in this class has a longer functional tail than its half-life suggests, and sleep is the first thing you lose.
- Use them for something, not as a habit. The compounds that carry tolerance genuinely reward intermittent use aimed at a task, and genuinely punish daily use aimed at feeling normal.
- One at a time, and long enough to judge it. This is the class where people stack five and cannot tell you which one is doing anything — and the effects are subjective, so attribution is already hard enough.
- If you need it to feel normal, stop. That is the line where a tool has become a dependency, and it is the one worth watching for.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- No routine marker tracks these. Sleep is the assay — if it is degrading, the compound is costing more than it is producing, and that shows up before anything else does.
Don't run this if
- A seizure history — several of these lower the threshold at least theoretically, and it is not worth establishing empirically.
- Bipolar disorder, for the dopaminergic members especially.
- Alongside prescribed psychiatric medication without knowing exactly how the mechanisms overlap.
The honest unknown
- Chronic use is essentially uncharacterised. The specific unmeasured thing is what daily cholinergic or dopaminergic pressure does to baseline function over years — not whether a few weeks is tolerable.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get L-Tetrahydropalmatine
Buy L-Tetrahydropalmatine at Disguised Alpha →L-Tetrahydropalmatine — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What L-Tetrahydropalmatine moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Most of this class has no predicted marker movement at all, and saying so is more useful than listing markers that will not move.
What to do: A baseline liver panel is reasonable for anything taken daily and long-term. Beyond that there is nothing specific to chase.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for L-Tetrahydropalmatine — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
Get the complete breakdown for L-Tetrahydropalmatine — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside L-Tetrahydropalmatine
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anaemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 102 markers A–Z
L-Tetrahydropalmatine — frequently asked questions
What is L-Tetrahydropalmatine?
L-Tetrahydropalmatine (L-THP / Corydalis extract) is a cognitive & mood research compound. Dopamine D1 and D2 receptor antagonist from Corydalis yanhusuo, used in traditional Chinese medicine for pain and sleep. The analgesia appears to be dopaminergic rather than opioid.
Is the full L-Tetrahydropalmatine protocol on this page?
The reported research dose is on this page, along with how L-Tetrahydropalmatine works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of L-Tetrahydropalmatine?
L-Tetrahydropalmatine has an approximate half-life of ~2–4 hours, which is part of what determines how often it's dosed.
What's the evidence behind L-Tetrahydropalmatine?
Current evidence level: Human trials in China for pain and insomnia; some data on reducing cocaine craving. L-Tetrahydropalmatine is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact L-Tetrahydropalmatine protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What L-Tetrahydropalmatine is used for
L-Tetrahydropalmatine appears under 1 goal in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.